×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KRON – kronos bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KRON
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/13
07:22 pm
kron
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Neutral
Report
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/13
04:05 pm
kron
Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
Medium
Report
Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
11/5
09:00 am
kron
Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
Neutral
Report
Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
10/23
08:58 am
kron
Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors [Yahoo! Finance]
Medium
Report
Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors [Yahoo! Finance]
10/23
08:55 am
kron
Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
Medium
Report
Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
10/9
08:55 am
kron
Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
Low
Report
Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
10/8
11:36 am
kron
Kronos Bio, Inc. (NASDAQ: KRON) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $6.00 price target on the stock.
Medium
Report
Kronos Bio, Inc. (NASDAQ: KRON) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $6.00 price target on the stock.
10/7
09:10 am
kron
Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren's Disease [Yahoo! Finance]
Low
Report
Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren's Disease [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
04:11 pm
kron
Form 10-Q Kronos Bio, Inc. For: Sep 30
Medium
Report
Form 10-Q Kronos Bio, Inc. For: Sep 30
11/13
04:07 pm
kron
Form 8-K Kronos Bio, Inc. For: Nov 13
Medium
Report
Form 8-K Kronos Bio, Inc. For: Nov 13
11/7
05:03 pm
kron
Form 8-K Kronos Bio, Inc. For: Nov 04
Medium
Report
Form 8-K Kronos Bio, Inc. For: Nov 04
10/15
06:57 pm
kron
Form 4 Kronos Bio, Inc. For: Oct 15 Filed by: Frisbee Allison
Low
Report
Form 4 Kronos Bio, Inc. For: Oct 15 Filed by: Frisbee Allison
10/15
06:56 pm
kron
Form 4 Kronos Bio, Inc. For: Oct 15 Filed by: Lin Charles Y
Low
Report
Form 4 Kronos Bio, Inc. For: Oct 15 Filed by: Lin Charles Y
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: